Health Canada
Document 10269064
Fields
- Notes
Selected on visit 1 (May 1999)
- Site
- Guildford
Document Images
Visit to Advanced Tobacco Products, San Antonio, Texas~
19th Februar7 ~985
Compiled b7 : A. L. Heard
Present:
N. Jacobsen
E.G. Vfmond
J.P. Ray
I. Hill
J.D. Simonsen
C. Warren
J. Unlack
J.A.B. Kellagher
R.P. Ferris
A.L. Heard
Chairman, C.E.O., A.T.P.
Chairman of Marketing Commltcee
President
V.P. Technology
V.P. Administration
T.T.L., Canada
BATCo Ltd.
BATUKE, R&D
BATCo Ltd.
Back~roun~
In November 1985, C. Warren and A.L. Heard visited ATF to
explore whether the potential existed for some form of
collaborative arrangements between their respective companies
and ATP, who had recently launched FAVOR, a smokeless
cigarette. At that time, ATP foresaw no problems in covering
distrlbutlon through USA but were interested In finding partners
who could develop non-USA markets. They were well disposed to
the BAT Group as a potential partner. Products were-supplied to
both ITL and BAT foI consumer test work.
BAT and ITL agreed that initially BAT, through the facilities
available to R.P. Ferrls of the BATUKE ReD Laboratory, would
conduct a detailed but small scale evaluation of regular FAVOE
with a brief assessment of some product developments made
available during the visit co ATP.
Additionally, B&W would be asked to monitor the performance of
FAVOR in the Texan cities where it was being launched.
Purpose and Scope of Meetin,~
In the period between the November visit and this visit, ATP had
suggested to ITL that they had further developments on FAVOR
including some which related to conventional smoke generatlng
products.
At preseat, in the secrecy agreements signed by ITL and BATCo,
our interests are confined to smokeless products and, so far,
have been strictly limited to cigarette-like products (FAVOR).
~a view of BAT research interests and background in smoke
generating products, including altering the nicotine/tar and
flavour contents, it was stated at the outset of this meetlu~ by
A.L. Heard that we did not wish to include on the agenda any
smoke-related information.
The purpose of the meeting was thu= ~o be confined to FAVOR and
to the marketing/product development issues.
mmlm~
O
O~
<:D
C li b PB'F-~- ~,'.G ~,',; ~:,,:~:f a's t'i'o-, c'o'm

- 2 -
In view of the value of the detailed findings obtained in the UK
study, ATP were asked to sign a secrecy agreement. They agreed
(the signed copy is nov with Legal Department, Millbank).
Finally, in order that, if necessary, information supplied to us
could be shared vith B&W, an alternative form of a secrecy
agreement, supplied by B&W, was signed by ATP and returned to
Legal Department, Bag.
Conclusions
There appear to be several important issues governing our future
involvement with ATP:
1. Do they have a concept which meets a real consumer demand?
On the basis of all the consumer studies done by ATP or BAT,
there appears little doubt that the consumer is seeking a
product of this kind.
2. Does the ATP product meet this concept (or will it by
reasonable developmental evolution)?
We must concede that, although there may be a small segment
of smokers who find the current product satisfactory, the
majority of consumers appear reluctant to use FAVOR Regular.
Whether this product can be modified to retain the consumer
is a key issue. We are confident that the ATP development
team, particularly if backed by BAT Group resources, could
make considerable strides in improving 'smoking mechanics'
and flavour. The real point at issue is whether ~he change
in smoking style demanded of the consumer by FAVOR relative
to conventional cigarettes will be acceptable in view of its
lower per puff nicotine and very low overall mass delivered
per puff.
3,
Only extended practical experience will answer this
question. Certainly, the more the basic mechanics are
improved the greater the likelihood of the consumer to make
the trade-off (which, of course, he may have to do many
times each day if he uses FAVOR as a partial supplement).
Is the ATP product protected by sufficiently robust patents
that others (including ourselves) cannot easily copy the
product?
The patent position is not clear and needs very close
investigation by expert counsel.
0
0
C IJ b PD'P-~- ~i:~t,?'. fiTsTi'oTc'o'm

-- 3 --
4 •
Alternatively, is ATP know-how such that they have a
valuable lead-tlme for us? (We cannot answer that question
in terms of our competlclou.)
The know-how that ATP have is certainly worth 2 years lead
time for BAT even if we gave such a project a high priority
in R&D, itself an improbable situation if viewed
realistically. We believe that subject to the continued
employment of the key Personnel (especially J.P. Ray and
I.D. Hill) the Company may be a most interesting proposition
because of the pot~ntlal extension of the technology Into
ordinary cigarettes, where use of the plug carrying
nlcocine/flavourants in a filter can improve quality of
conventional smoke.
5. ghat is the worth of ATP?
On current performance in the test markets (using largely
ATP indications) the company must be seen as high risk and
worth far, far less than the $300 m projected by ATP. We
are basically looking at an R&D company wlch a good concept,
good know-how, useful production facilities but no proveu
market - indeed, if anything, it has a disillusioned market.
Other factors which may adversely affect the viability or
profitability of Favor in the US market are the possibility
of FDA regulation (even to the extent of prohibiting the
product), of becoming subject to Federal Excise and Sta~e
taxes as a tobacco product, and of the imposition of
Advertising restrictions. Any such development would also
then have implications for the product in other markets.
If we wait until market share rises and approaches the 1%
ATP expect by 1987, the buy-out price could be around
$300 m.
If, on the other hand, market share remains at 0.4% or,
indeed, falls, or if the product returns predicted by B&W
materialise, the company is likely to be in serious
financial problems and could be purchased at a low price ($5
- I0 m?).
&ecommendatious
The sltuaCion argues for the following possible courses of
action:
Technical/Markettn# Strate$7
1. Check ATP patent situation. If not robust, we should
consider withdrawing since others will 'move in'.
2. Check the toxicological information, taking expert advice on
the safety of FAVOR.
3. ITL should proceed wlth their plan to run an extended study
on 400-600 consumers using the FAVOR variant best suited to
the Canadian market.
<:D
~O
C I i-b-P[9F'-~- t,? ~,,'J ~,,'Jtla's.t'i'o'r¢'o'm

- 4 -
~o
.
6Q
BAT should extend the A0-person monitor on potential FAVOR
usage iniClaced in January 1986, Co test the ~Ime dependence
on views elicited from thac pilot study.
B&W should complete the 1000-smoker Texas-vide telephone
study scheduled for completion end-March. This-should
provide corroboration of the ATP study nov being analysed by
Marketlng Department, Hillbank.
Evaluation of current marker position in the field by BAT
Marketlng management.
Business Strategy
1. In the short term ITL and BAT should maintain dialogue rich
ATP.
In the light of knowledge gained from the above initiatives,
BAT/ITL might consider in exchange for:
(i) input of their own technology
(i£) assistance An distribution from B&~
(ili) S one-off payment to ATP
a) Exclusive rights to all smoke-related applications of
ATP's current future technology and patents.
b) An agreement that ATP ~ill restrict the expansion of
FAVOR during the next 12 months to permit further Joint
development of the product co eliminate or minlmise the
negatives revealed so far by research.
c) BAT/ITL would be given an option on the purchase of
shares in the company producing FAVOR on a performance
related formula: the option to. remain valid for 18
months.
d) Any payments or know-how contributions from BAT vould
be capicallsed if the option co purchase a share and
participate in the equity of ATF is taken up.
O
G
C7~
C l i I~P'D'F - vv vv vv. f ~--~t, o. c o Ill

- 5 -
Karketln6 and Sales Situation
No Harketlng presentation was made by the ATP Board to give us
any real information about strategy, advertising, current sales
and distribution arrangements etc. We were informed only that
FAVOR vas launched in the last week of September 1985 in Austin,
Texas (which represents O.3Z of the United States market) using
a Broker and Wholesalers and that distribution yes extended to
Hetro Dallas in November and rolled out to Houston in January.
They intend to continue a roll-out to cover the whole of the US
in ten steps completing step one with extension to the remainder
of Texas, California, Arizona and Nevada in the near future.
The objective stated by Ed Vtmond (vho was hilled as Director
and Chairman of the Marketing Committee) was ~o achieve a major
share of the US Cigarette Market. It was only subsequently that
it emerged that this major share objective vas in fact 1Z.
Hr.
Vimond who vas President and CEO of RJR Xnternattonal from
X980-1982 was not particularly impressive.
Subsequent to the visit J.A.B. Kellagher read two New York stock
exchange reports relating to ATP, one of which dated 30th August
1985 included In the 1let of Officers and Directors, Hr. Jim
Rarkness under the title of VP Harketing. There is no mention
of him however in another report dated 9th September 1985 and he
was neither present nor mentioned at our meeting, wo it may be
assumed that he has left the Company.
ATP has recently completed a Favor Attitude and Usage study
based on a telephone interview survey carried out in the Austin
initial market after the first thirteen weeks. No management
analysis of these results was presented except for the
information that the product had achieved 91Z awareness amongst
smokers, that 55X had tried Favor, 33Z had actually bought Favor
themselves and 4Z are currently using the product. The share of
market calculated by them on the basis of the research
Information results in a figure of 0.9Z of the Austin cigarette
market for the whole 13 week period and 0.4Z current share.
Share figures, incidentally, are all calculated on a per pack,
not per stick, basis.
The research revealed that current users are 65Z female and tend
to be upper income, white and aged 35+. The full Survey report
has, however, been broughc back to Hlllbank and a more detailed
analysis will be prepared.
~r. Vtmond claimed chat ATP had gained a good breadth of
distribution and that only two firms had turned down the product
buC admitted that ATP eere lacking in depth o~ distribution due
to the absence of any field-force. This, of course, is one of
the reasons that they are anxious to form an association with a
large F~CC company and preferably a tobacco company.
C li t~'P-D-F - ~la-"~i~i

- 6 -
~r. Vimond was informed that the information we had received
from B&R suggested that although substantial quantities of Favor
had been dls~ributed to the Trade much of this stock would, in
due course, be returned. Hr. Vlmond denied that any stock had
been returned. It is worth ootlng, however, that B&W obtained
this information from their Broker in Austin which is the same
ss that used by ATP.
Hr. Vimond predicted that market share would now steadily
increase, claiming in effect that 0.&X share is the bottom of
the curve. When questioned ou this subject, however, there
appeared to be no'statistical or other objective Justification
for this expectation.
Production process
A visit was arranged Co see the production facilities and
laboratories. The factory is clean, bright and tidy as are the
adjoining quality control/research facilities.
FAVOR comprises an extruded plastic (85 mm) tube containing a
small mioroporous plug (9 mm) vlth a brovu tipping paper at the
mouth end ~remoce from the plug). The microporous plug contains
adsorbed high purity free nicotine and selected volatile
flavourants.
Impure nicotine (extracted from tobacco) is imported as a 95Z
(impure) extract from India and is distilled (in a plant located
outside of city limits for t6xicological reasons) to better than
99.9X purity. This is diluted eith ethanol and flavourants
added. A batch of plugs checked for pressure drop is floated ou
this solution and by applying a vacuum, the air is removed
enabling the nicotine solution to penetrate. Solvent is removed
by rotary vacuum drying leaving pure nicotine/flavourants
adsorbed on the pore surfaces. According to Dr. Z. Hill, the
dimensions of the plug/pores places an upper safe limit on
nicotine loading, a feature ehich will need careful probing if
collaboration is pursued.
The plugs are transported in sealed churns to the assembly
factory situated at the rear of the ATF office premises. This
occupies 25,000 (?) sq. ft. Currently, ATP have two making
lines from blank cubes to wrapped cartons, ac present laid out
in the typical U-conformation of a cigarette making assembly.
(This rill be replaced by an in-line conformation when these two
machines are transferred co the adjoining building where tvo
other assembly lines are being built.)
Blank tubes of double FAVOR length are fed by hopper Co a
grooved block which transports them approximately 1.5"metres by
which time plugs are rammed into either end of each Cube. Tn
the subsequent operation, tipping is applied co the centre of
this dual rod and the rod is cut. The product (6 to a pack) is
sealed ou a heat seal chocolate wrapping type machine and packed
in a hinge-lid box.
G
ClibPDF - www.fastio.com

- 7 -
Production, which is currently packer speed llmlced, is between
80 and 130 packs/minute.
ATP claim chat on four shift operation the four production lines
soon co be available will be capable of supplying the 1Z market
share they foresee for FAVOR within the next year.
Patent Position
ATP claim that their issued US patent (No. 4,284,089) covers
securely the basic principle of nicotine volatisacion implicit
in YAVOR. They also cited the EEC patent applications (already
known to us) and stated that other patents on details of
construction etc. are in progress.
A.L. Heard expressed his concern for the robustness of the US
patent following a first survey by BAT Patents Department. He
expressed an intention, fully agreed by ATP, to explore in depth
the soundness of the ATP patent position since this is a
keystone of any collaboration.
Toxicolo~ical DaCe relatin~ co FAVOR
ATP provided both BAT and TTL with a copy of a 30-page document
eutitled "Toxicology of Nicotine Base - an assessment for ATP"
by Dr. Daniel M. Fords a consultant toxicologist. This covers
the acute and chronic toxicity of nicotine and goes on Co
consider implications for FAVOK. Abuse, risk to children and
workers are considered.
The conclusions suggest no real concern but the document has now
been passed to T.G. Mitchell of BATUKZ KaD for expert comment.
ATP were made aware of the kind of requirements that the BAT
Additives Cuidance Committee would seek in approving use of
~AVOR or similar items. It was made clear that BAT would, if it
pursued further with ATP, ask for all confidential details of
ingredients, materials etc. to be disclosed to a nominated
person.
UK Consumer Stud~ on YAVOK
The results of a small-scale consumer study carried out in UK
using Regular FAVOK were shared with ATP (under a Secrecy
Agreement). The'trial was based on 40 subjects selected by
delivery, sex and concern (expressed as ability to cope for
• periods without cigarettes). The study was divided into three
stages:
Cr~•
0
C I J bpIDF - ~J. f ~TWti 0-. c o ill

- 8 -
1. introduction co concept and produ:c
~a
a ~-hour period of clKarecce deprivation buc free
access co FAVOK
a &-day period of free choice - conventional clsareCCes
or FAVOR ac will
The findings are summarlsed in the attached uoce by R.P. ¥erris.
ATP vere excreme&y interested in our findings and were clearly
i~pressed by the skill shown in both constructing and
implementing such an informative study ac short notice. They
were quick co see the benefits that access co the BAT Croup
techniques and knowledge of cigarette design and human
smoking/preference could brine Co them in the developmenC of
FAV0~.
Development Potential of FAVOR
Two features distinguish FAVOR from ocher nicotine-delivering
alternatives co the conventional cigarette (e.g. sums, tablets,
dry and wet snuffs):
a) the delivery device is physically and visually very similar
to conventional cigarettes
b)
the mode of delivery, albeit vapour and noc aerosol based,
relies on inhalation in a personally controlled series of
puffs.
These are extremely important features in chat Chef offer
familiarity to conventional cisaretCe smokers.
However, FAVOR has important known constraints. Firstly,
nicotine delivery per puff has been maxinised at 10 us, only 10Z
of the typical nicotine level/puff from a eouvenclonal mld-car
cigarette. The potential of one stick to yield up to tO0 such
puffs leads co a behaviouraI chanse in the direction of more
rapid puffins by the user. Hore importantly, the Coral matter
delivered per puff of FAVOR is merely ~Z of Chat from a
conventional mid-tar cigarette. This will call for considerable
ingenuity in product modification co restore traditional sensory
cues such as mouthful and reward for draw effort. Dr. Hill will
seek to achieve such improvements by selection of approved
volatile flavourancs.
o
C~
Cr~
U~
~mmm~
Clit~PDF - www.fastio.com

- 9 -
Potentlal gAY Asslst~nce in FAVOE Development
There are three ways in which ATP development of FAVOR could be
accelerated if BAT resources were made available:
C1)
Sensor7 Development
ATP currently use ad ho¢ in-house evaluations for
sensory assessment of the product. Lack of a panel
approach using a set of standard attributes means that
ATP have not crated their progress with a development
history of comparative sensory profiling. BAT research
has established a basic sensory pro£iling technique
which can be used to indicate sensory shortcomings and
provide guidance on levels o£ sensory magnitude which
would improve product acceptability. Notably TAVOE
~CULAR shows problems on taste level (too low)
irritation (coo high) and mechanics (poor perceived
draw due to the fact that ATP wrongly define draw
ef£ort in terms of measurable draw resistance instead
of against the consumer criterion of reward for draw
effort).
BAT sensory pro£iling of ATP's more recent ex~erimental
prototypes shows chat these problems are surmountable
~o some large extent. Use of a sensory testing
approach would significantly £ocus and speed up the
current empirical approach and should concentrate on
determininS the interdependence og mechanics and taste
masuicude perceptions (the two seem to interact such
chat increasing taste magnitude will produce improved
perceived mechanics even against a fixed measurable
draw resistance baseline). The method should also
allow an understanding of the relative contribution or
salience of particular sensory attributes co overall
product acceptability. Ic will be important to compare
such a "contribution heirachy" for FAVO~ with that more
typical of conventional cigarettes. Looking at the
same problem from the consumer perspective, it will be
important to understand relative sensory requirement
hairachies of low and full £1avour smokers if KEGULAK
and LIGHTS versions of FAVOR are Co be successfully
di£ferentially marketed to such consumers (at present,
data on FAVOR REGULAR shows no differentiation of
sensory response by delivery level of smoker, buc a
clear dif£erenclacion by acceptability).
Cli)
Behavioural-Heasuremeut
Diary monitoring of FAVOK use patterns indicates that
the product is used in a very dif£erenC manner to
conventional cigarettes (often in use continually for
periods of over one hour) and chat its use alongside
cigarettes is associated with a reduction in cigarette
consumption. Sensory testing also indicates that
'getting the mechanics right' (i.e. achieving an
appropriate effort/reward relationship) is key to
product acceptability. A central issue concerning
C7~
C li tiP D-F - ~1 a-~'tT6T'_~oWfi

Clii)
- 10 -
eventual success/failure of FAVOR will be whether users
can learn to trade getting nicoClne in large doses from
a small number of puffs for the FAVOr alternatlve
(small per puff dose, large number of puffs). The
observation that cigarette consumption declines when
FAVOR is used supports the view that FAVOr Is
satisfylng a pharmacological demand. Therefore the
prime use of behavloural measurement would be to ensure
that the sensory cues driving smoking behavlour are
optlmised.
Smoker effort can be measured dlrectly as puffing
pressures aud'volumes using smoking behaviour
equipment. It should be technically feasible to
convert current equipment to monitor FAVOR smokers and
derive the following important information:
a)
A concrete measure of smoker effort being applied
to an7 FAVOR variant, which can be used as a
criterion for arrlving at satisfactory
'mechanics', and may also be correlated to sensory
perceptions of draw effort.
b)
Characcerisation of physical smoking style learned
in using FAVOR relative to conventional
cigarettes.
c)
Examination of how critical the role of
satisfactory mechanics will be in FAVOr
acceptance. Will the most acceptable FAVOr simply
be the variant with the best effort-reward
relatlonshlp (i.e. closest to conventional
axpectatloos) or will the quallt~ of reward £n
taste and irritation terms support trade offs
against the effort criterion?
Product *Cosmetics'
UK qualitative work has defined a number of
product appearance factors which aeem to
contribute significantly to product
acceptance/rejection. Most notable of these are
tactile feel of the rod, requirements for more
perceived solidity at the mouth end (perhaps by
use of a baffle), stick use/depletion indication,
improved (preferably single stick) inner wrap,
improved pack design (in terms of function and
appearance).
While ATP are larsely aware of these aspects, the
use of a panel of *Innovation sensitive'
consumers, such as are available in the UK for.
qualltatlve evaluation would he a considerable
asset.
.....a.
O
r~D
O',
O
ClibPDF - www.fastio.com

- 11-
ATP Business Plan
ATP have noc flnallsed a business plan. Nevertheless, Dr.
Jacobsen van prepared co oucllne the way he saw FAVOR earnings
developing and the options for involvement vlch potential
partners.
Earnings:
1986 - profitable
1987 - $25 m net earnings pre-tax
1988 - $50 m " " "
1989 - $100 m " " "
This is based on 25Z profits on sales assuming no 'tobacco' tax
is imposed. However, ATP were keen to stress that the current
product is certain ~o reduce in cost as new ideas and process
improvements are made. The high gross margin (>70Z) for this
product (which would be still >60Z if tax were imposed) means
that providing the market share reaches a level of general
availability, profits should be very high.
ATP believe FAVOR could be a 'white hat' product (implying that
it has an attraction Co medical groups, government and even
anti-smoking factions,) and could be strongly supported.
Zn the patent area ATP believe they are strong but recognise
that their tr~e technical asset is in 'know-how' which they
estimate equates to a 2-year lead rime. (We do not disagree.)
In view of the positive outlook, ATP see for their product (once
optlmised), they estimate company worth at $300 m based on the
2-year post tax profit ($15 m) combined with a 20 multiple.
In terms of participation by other companies, Dr. Jacobsen saw
three possibilities:
i. Buy out
2. ~uy in at a percentage
3. Licensing arrangements or Joint Ventures.
He seemed to favour option I. with the second option being 2.
but 3. was not particularly favourably viewed. However, a
combination of 2. and 3 was not discouuted. One possibility
that ATP foresee for spreading activities internationally with a
partner is to operate a 'Coke syrup' philosophy, l.e a key
element of the process could be manufactured centrally in San
Antonio and shipped to YAVO~ manufacturing locations (it is easy
Co envisage the ntcotine/flavour plugs being so handled).
Although not made clear, there was a suggestion Chat ATP are
encountering distribution problems in USA and would welcome
collaboration with a domestic US cigarette company.
ALH/DET
7th March 1956
Distribution:
Messrs. E.A.A. Bruell
J-L Mercier
C. Warren
J.A.B. Kellagher
R.P. Ferr£s
O I J b P~E~.F---v.,z.vv.wd@s+i.o-:c o1~:1

~ote to J.A.~. Kellagher, Esq.
FAVO~ Research P~porc - United SCares
You asked for coffiments on the data relating Co the post-launch research study
" of FAVOR smokeless cigarettes in a rest-market area of the United States.
519 smokers were questioned by telephone, a sample which yielded 20 current
users of FAVOR and in order co boost this nuaber a further 30 users were
contacted.
Before ccmnenCinE on the findings there are one or two points which I should
make about the val/dity of the data.
11
Our ability to say very much ~rlCh confidence about the outcome of any
research study must always depend on its scale and where this
particular type of project is concerned IC is only rarely thac we find
thac sufficiently large samples have been used to permit a reliable
comparison of Important sub-groups - for example buyers versus
non-buyers of the p~oducc in terms of their comparative make-up by age
and regular brand. Thus, such comments as ~ ,m able to make on
differing patterns of behaviour or acclcude as-between the breakdowns
by which the data is analysed mUSts for the most part, be tentative
rather than firm: there are many tendencies and indications apparent
in the data but few conclusions to which sign/ficance in terms of the
conventionally acceptable level of statistical reliability can be
attached.
~e
Current users of a test-product are inevitably of particular interest
in such a study but severely constrained by total sample-size. In
this particular case the initial study yielded only 20 current users
of FAVOR and even when boosted they totalled only 50. Such samples
permit us to say very little with any confidence and in this instance,
the situation is worsened by the possibility that the boosre~-sample
has distorted the picture: the additional users were found by
non-random means and comparison with the ma/n s"mple data suggests
that they are excessively skewed towards women and older smokers.
Without a 1-arKer user-sample, found by more representative methods
(e.g. by inserting questions on an Omnibus or sim~larly large study)
it is impossible to say vhat is the true age, brand and sex profile of
those who are still using the product.
Finally, in order to maximise the information on which analysis was
based these additional users were added into the sample wherever
possible and althouEh the effect is more diluted, this Coo may have
had some adverse effect on such data as the total buyers' normal
cigarette-type.
3,
It is difficult to assess the representativeness of the basic
smoker-sample: the profile by segment under-represents smokers of
regular cigarettes and over-represents lights smokers when set against
Maxwell nation-wide sales figures, the only data available to me.
However, this could he due to regional differences.
CD
~4D
G
t.n
°.
C li b P D F - vvw-w~l a.st.i,(~c~(~.r-l-1 ....

~o
-2-
Awareness
Smoker-awareness of the new product is remarkably high, at 91%. It is higher
among men (93Z) than women (88Z); it rends Co be slightly higher among the
youngest age-group (the 18-24's) and lower among the over 50'8. And smokers
whose daily-consumption of conventional clgarecces is classed as 'moderate'
appear also to be rather more aware of the product than ocher smokers.
Trial
Over half of all smokers quesCloued had Cried the product, and men to a greater
extent than women. The pattern of trial by age and by normal clgareCte usage
is similar to that for awareness.
Purchase
One in three of all smokers had got as far as buying the produnC. Men and
women appear Co have done 8o Co an equal extent, as did all age-groups bu.t the
over-50's, of whom only one in four made a purchase. 'Moderate' consumption
smokers were signlflcancly more likely to buy than ochers.
Of Chose who had ever bought the product, however, only 12Z (4Z of all smokers)
were still using £t aC the C£me of the research and-although they were drawn
equally from the sexes and the three cigarette-cons,-.pt$on groups, the
age-groups show a more marked fall-off in buying among the under-35's than
older smokers, There are indications (but no more than this) Chat users may be "
sllghcly'skewed towards the upper educaclonal groups and towards ~.ce~ rather
than Blacks.
The brand-share profile of chose smokers who were aware of FAVOR, Cried lc or
purchased it approximates to that of the smokar-semple as a whole but Marlboro
smokers appear to he slightly under-cepreeented when it comes to pnrchasln8 the
product.
Source of purchase
There were no significant differences in the place of purchase as between the
first occasion ou which FAVOR was bought and the most recent occasion. Nearly
half of all buying Cook place in a Supermarket (46Z), and the next most
important outlet was the Convenience S~ore (37Z). Drugstores accounted for 7Z
of purchases, and r~scounc Stores 3X.
The incidence of buying in Supermarkets and Drug Stores was markedly higher
among women and older smokers, while men and the under-35's were more likely to
make their purchases in a Convenience Store.
~xD
C3~
Crx
C li b P D F - w.w.w-l.a.s¢i,®-.e®,m

-3-
The pattern of source of purchase as between first-films buyinE and the most
recent occasion vas the same.
~uanetcy purchased
Whereas normal cigarette purchases vere predominantly (67Z) made in cartons,
purchases of FAVOR vere almost invariably (96Z) in indLvidual packs: 84Z of
purchases ou the last buying occasion cook the form of a single pack, and a
further 10Z, two packs. Female and older buyers, however, tended to show a
higher incidence of two-pack buying.
Froduct-type purchased
The majority (84Z) of smokers of "regular" cigarettes bought the regular
version of FAVOR, and 75~ of menthol cigarette smokers boushC the menthol
version. Those who normally smoked lights, however, were much less likely co
buy the lights version: only 37Z did so, the majority (58Z) buying regular
FAVOR.
The nec result of this was ehac over half of all buyers chose the regular
version, a quarter Che menthol, and the'remainder the lights.
Former users
88Z of those smokers who had st esme t4me bought FAVOR had discontinued using
it. Of these nearly half had made use of the product for only one day, and
tthree-quarters for less than one week. Regular smokers of a menthol brand and
those ~ao boushC the menthol verslou of the FAVOR product appear to have
abandoned FAVOR =ore quickly Chart other smokers: 87Z of buyers who normally
smoke menthol dropped the use of FAVOR ~chin a week of trial.
Nevertheless, a small core of smokers (around 10-15Z of FAVOR purchasers),

.j
m
-4-
Asked the likelihood of their buying the product at some c~ne in the future,
those former users who had last bought the lights version of FAVOR and who were
in the 25-34 age group Cook a rather more positive attitude than other
respondents. •
Current users
As my opening remarks indicated, the small size of the coral user sample (51)
and uncertainty as to £Cs reliabilicy restrict firm to,went on this particular
sub-sample, and especially the user-profile. However, if we ass~e Chat it
fairly reflects current buyers of FAVOR, the following points may be noted:-
Ii
14% of current buyers had made use of the product on the day they were
contacted, and about 50% between one and seven days ago. Only 14% of
the sample used more than one FAVOR cigarette per day.
2o
8% of current users claimed to have bought a carton at their last
purchase buc nearly three-quarters had bought only one pack.
6
1~ used FAVOE only in situations in vh/ch they were free to smoke
conventional cigarettes; 40% used FAVOR where conventional smoking was
forbidden, and the remainder in both smoking end non-smoking
situations.
4. It is particularly interesting Co note ChaC a high proportion of
current FAVOR users said that they were using the product in order to
help cham cut dovu their e~ok.'Lng of regular cigarettes (25%) or as an
aid Co quirting sacking all together (22%).
The next most frequently mentioned reason was as an alternative co
regular cLgaretCes in a non-smoking situation (35%); and, third most
often mentioned, as a means of avoiding offending others (29%).
t" ~%." of current users believed ic co be safer than regular ~igarectes.
5. Asked ~hat they liked about the product ~ 44% of current users praised
ice Satisfying qualicles. Posiclve c~eut on Caste aspects, however,
li were considerably lower,
at
16%.
The majority of favourable responses related to the absence of "smoke
(58%), and 22% singled out the fact Chat FAVOR was noC offensive Co
ochers. No ocher favourable comments were made by more than 6% of
users •
0
G~
ClibPDF - www.fastio.conl --

-5-
7e
Users' volunteered dislikes were ma£nly centred on the pc.duct's taste
characteristics (35Z) and a lack of satisfaction (31Z). OoJ.y 14%
missed the smoke from convenct0nal cigarettes.
Crct7 one-third of current users agreed chac Chef would definitely buy
the pc.duct in future, although a further 45Z said thac they would
probably do so.
Main conclusions
lm
Awareness, trial and initial purchase In the rest-marker area were
undoubceck~y high.
B
Hovever, early rejection of the produce after initial trial was also
high, largely for Caste and irritation reasons and a lack of
satisfaction - criticisms made even b7 current users. The menthol
version appears Co be less successful in produce terms than the lights
and regutar versions.
.
The absence of smoke does not appear to be a major obstacle to
acceptance.
Information on the reasons for purchase is confined to tie small
s=mple of current users. Nevertheless this indicates a strikingly
high claimed level of the use of FAVOR as an aid to cutting down or
quitting smoking, as well as a solur~ton co the problem of nou-mok£ns
situations.
.
Those smokers clain~nS Co be us~ FAVOE at the time of the research
totalled'some 4Z of all smokers; however, less than one in seven
current users were found to have used the produce on the day of
interview, and oul~ one in three said that they would deftnicely
continue to buy the produce.
Thus, although the concept has plainly g~nerated a high degree of
interest and trial the attrition-race is also high and it would be
interesting co re-cent-act current users ac a later date co find ouc at
whac level purchase finally settles. On its present showing the
product, as currently marketed, does not appear to represeuc a serious
threat Co cigarette-sales.
7thPLarch 1986
C.J. Pendrr
cJP/~0c
o
LIl
C IJ b P DF~--~,7~,'~W-f astioTc-orfi ....

ADVANCED TOBACCO PRODUCTS, INC.
February 19, Z986
lCeeCing: 9:00 AM
Par~£cipan~s
Alan Heard
Cliff Waz-ceu
Jim Yniacke
Robb ¥erris
- BAT
- Imperial Tobacco Ltd.
- Imperial Tobacco Ltd.
-BAT
Alan F,.ellagher - BAT
ATPI
Norman L. Jacobson, Chairman and Ch'(e£ Ex.ecueive Officer ~./e-mmzl~a~
J. Philip Ray, President e"~'m~,~Q,/~ee,KC/4,,,Cmb,o~
Edmond C. Vimond, D£.reccor, Chairman o£ MarkeCCnK Committee ~ ~ /~t
Ira Hill, Vice Pzes£deut, Technolosy - t~/¢,e, mv-¢~.,~e,,.m,m,~
James D. S~noneeu, Vice President, Administration ~ ~,~/~ zese~mes/waNh~r
0
r'O
0",
0
0",
0
C l i bPDF - ~ cq--Stl o. c o ii1
" "

FAVOR U.K. RESEARCH FOLLOW UP: FURTHER CONSIDEP~TIOIIS
Previous U.K. research on the FAVOR product has indicated that, in the
short term, response to the concept Is hlghly favour~ble whllst response
to product ts somewhat less favourable. Price elasticity of demand for
FAVOR REGULAR is htghly Inelastic, but becomes elastic tn relation to
other product variants sampled.
It now becomes necessary to examine longer run trends fn attitudes and
usage of FAVnR. Three al ternatlve research strategies are posslble, all
of which assume that a pre-product screening exerctse will have been
performed on ATP's range of product variants in order to determine the
optimal product for placement:
Ii
EXTEHD THE CURRERT POSITIOiI i.e. 6 week placement wlth existing 40
respondents using dlary monltoring, weekly attltudes/usage questionnaire,
butt collectlon and weekly product placement.
STRENGTH: low cost.
WEAKtIESS: professlonalt sed and biassed panel.
e
COST: c. £6,000
VALIDATE nH A DIFFERS)IT PAHEL i.e. Inltlal concept aualitatlve
sessions followed by 6 week placeuent wtth new sample of naive
consumers {c. ~0) again using diary monttortnq, weekly attitudes/usage
questionnaire, butt collection and wc~ekly product ptacenent.
STRE)fGTH: validation of earlier work, avoidance of 'loyal
responding'.
WEAKt!ESS: cost of pre-recruitment.
1
COST: c. £9,000
SITI'JLATED TEST tIARKET MOnFLLItlG: i.e. to use a new sample and apply
a classic ASSESSOR evaluation to promote trial, re-trtal and subsequent
modell I ng of long run market share.
STRENGTH:
WEAKNESS:
will provide a prediction of product performance in
the marketplace in ter~s of share.
within reasonable costtng,saemle stze would be small
(c. 60) therefore accuracy of prediction would have
high error variance. Loss of richness in usage/attitudinal
information would occur.
COST:
C. £11,000
C~
",C)
C~
(~
CP~
C li b P D F °--'VC/'C'~W':fra's't'i'oTc-o~ll

-2-
Choice of option is heavily dependent on whether the objective ts to
learn more in depth about attitudes and usage trends with time, or to
atilt predictions of market share potential on the basis of some
reallstlc purchase opportunity situation. The former objective is addressed
by options I and 2, of which option 2 is the most desirable since it
combines validation with a move to a less biassed sample base. Ootlon 3,
while attractive in commercial decision making terms, really requires e
much larger sample slze to be done well and Is, in any case, somewhat pre-
empted by Al~ providing, In effect, a ready made test market (assuming we
can monitor it satisfactorily).
PRICING EFFECTS
Earlier discussions lead to the view that product placement would be by
purchase of both FAVOR and own brand conventional cigarettes at an equated,
lower than Market, rate. Whlle provldlng a welcon~ element of 'hard
reality' Into the testing sltuatlon, the Introductlon of a purchaslnq
varlable carrles several problems:
I.
Sample size is already small and would reduce to unrealistic levels,
even by the most optimistic prediction, If a purchasing criterion
were introduced.
1
Consumers are very uncomfortable buylnq supplies of clgarettes on a
weekly basis.
.
To achieve an equated price slt.atlon means either conventional
cigarettes will be priced unreasonably low, or FAVOR may be orlced
too hloh (relative to perceived costing data from the earlier study).
In either case. 'normal' consumption patterns will be significantly
distorted.
4t
Relaxation of the requirement to equate on price begs the nuestton
"what should be the price for FAVOR?'. This question is complex and
outside of the scooe of a small scale exploratory study since price
elasticity of response at various pricing pitches would have to be
modelled.
RECORV£NOATION
Since the scale of thls U.K. research wlll not support a credible evaluatlon
of long run market potential of FAVOR, and since this objective is
currently better addressed by researching the llve market and by the
proposed Canadian study, tt ts recommended to droo the purchase variable
from U.K. research stnce at best tt wtll reduce available data and contHbute
significant bias.
Concentration on the objective of tn-depth diagnostic research on usage
and attitudes would be most suftably achteved through Option 2 (with
perhaps a low cost parallel placement to the orlgtnal sample).
R.P.FERRI$
RPFIBCH
13.3.86
0
P~
C~
P~
C l i b P-D.F - ~ v.w.w~.l.a-s.t.i,o-, e®.m

Mr. R.P. Ferrls/JJ
27th February, 1986
DEVELOPMENT POTENTIAL OF THE FAVOR PRODUCT
Two features destlnsuish FAVOR from other nicotine delivering
alternatives to the conventional cigarette (e.g. gums, tablets, dry and
wet snuffs):
a)
the delivery device Is physically and visually very similar to
conventional cigarettes.
b)
the mode of delivery, albeit-vapour and not aerosol based, relies
on inhalation in a personally controlled series of puffs.
The presence of these features is highly significant, since the
former all.as the user to re-assemble the familiar gestural routines
associated with smoking around the new behav£our of raping, and the latter
ensures the high efficiency pulsed dose lung uptake which is central to
the development of a behavlourally reinforced product use pattern.
In developin8 the potential of the FAVOR product, one
known constraint Is thac the nicotine delivery potential per puff hss
been optlmlsed to a ceiling of c I0 micrograms per puff, therefore future
development wlll be about optimlslng stimulus values of the sensory and
physical context which the product places around a nicotine element which
is essentially providing lower per puff nicotine levels across an extended
puff number potential (90 - 100 puffs per stick).
It is significant that FAVOR development thus far has been
considerably faster than new product development cycles typical of corporate
R&D. This is due co the small scale entrepreneurial nature at ATP linked
with unique high level capability in nicotine delivery development and
flavour formulation. A corporate R&D approach to support of ATF should
be avoided in favour of a fast, praKumCi¢ and product oriented input,
ideally 'hands on' alongside Ira Hill on whom most tertiary development
of the basic product wlll now begin to rely.
BAT could prow/de product development support at 3 levels:
Sensory Development
ATP currently use ad hoc In-house evaluations for sensory
assessment of the product. Lack of a panel approach uslnE a set of
standard attributes means that ATT have not traced their progress wlth a
development h/story of comparative sensory profiling. RAT research has
established a basic sensory profiling technique which can be used to
indicate sensory shortcomings and provide guidance on levels of sensory
maEuitudewhiohwould contribute to improvements of product acceptability.
Notably FAVOR REGULAR shows problems on taste level (too low) irritation
(too hl8h) and mechanics (poor perceived draw due to the fact that ATP
wrongly define draw effort in terms of measurable draw resistance instead
of against the consumer criterion of draw effort in relation to achievement
of a given sensoric reward).
P~D
CD
C li b P D F - vvw_w,.ta,sI, i.o,.,c- o.ra.1.

-2-
BAT sensory profiling of &TP's more recent experimental prototypes
shows that these problems are surmountable to a large extent. Use of a
sensory testing approach vould significantly focus and speed up the
current empirical approach and should concentrate on determining the
interdependence of mechanics and taste magnitude perceptions (the ewe
seem to interact such that increasing Caste magnitude will produce improved
perceived mechanics even against a flxed measurable draw resistance
baseline). The method should also allow an understanding of the relative
contribution or salience of particular sensory attributes to overall
produce acceptability. It will be important to compare such a "contribution
he~rarchy" for FAVORer lib that more typical of conventional cigarettes.
Looking at the sme problem from the consumer perspective, it ~ll be
important to understand relative sensory requirement heirarchies of low
and full flavour smokers if ~ and LICRTS versions of FAVOR are Co
be succesfully differentially marketed to such consumers (at present,
data on FAVOR ~CULAR shows no differentiation of sensory response by
delivery level of smoker, but a clear differentiation by acceptaSility).
A highly time/cost effective model of consumer preference
testing will also be key to screening variants follo~rfng the rather more
diagnostic role that sensory panels may provide. BAT's PR~FAN model
using small samples wtth statistics which preserve independence of
respondent scoring behaviour would be particularly appropriate.
Behavioural Measurement
Diary monitoring of FAVOR use patterns indicates thac the
product is used in a very different manner to conventional cigarettes
(often tn use continually for periods of over one hour) and that Its use
alongside cigarettes is associated with • reduction in cigarette consumption.
Sensory testing also indicates that 'getting the mechanics right' (i.e.
achieving an appropriate effort/reward relationship) is key to product
acceptability. A central issue concerning eventual success/failure of
FAVOR~r~ll be whether users can learn to trade getting nicotine in large
doses from a small numSer of puffs for the FAVOR alternative (small per
puff does, large number of puffs). The observation that cigarette consumption
declines when FAVOR is used supports the view that FAVOR i seattefying a
pharmacological demand therefore the prime use of behavtoural measurement
would be to ensure that the sensortc cues driving smoking behaviour
(notably chose concerned ~th perceived effort) are 6pttmised.
Smoker effort can be measured directly as puffing pressures and
volumes using smoking behaviour equipment. St should be technically
feasible to convert current equipment to monitor FAVOR smokers and derive
the follo~ng important information:
i)
A concrete measure of smoker effort being applied to any FAVOR
variant, which can be used as a ~riterion for arriving at satisfactory
'mechanics', and may also be correlated to sensory perceptions of
drav effort.
ii)
CharactertsaClon of physical smoking style learned in using FAVOR
relative to conventional cigarettes, and evaluation of smoker effort
modelled by delivery level of smoker.
mmmab
G
Cr~
ClidP-D-F - v.~/~/,,/\,vi,'a{[io.col]l
--

-3-
ill) Exan~natlon of hc~crltlcnl the role of satisfactory mechanlcs
will be In FAVOR acceptance. Will the most acceptable FAVOR simply
be the variant ~rlth the best effort-reward relationship (i.e. closest
to conventional expections) or will the quali~of reward in taste
and irritation terms support trade offe against the effort cr~terion?
Product 'Cosmetics'
U.K. qualitati~e work has defined a number of product appearance
factors which seem to contribute significantly to product acceptance/rejection.
Most notable of these are tactile feel of th~rod, requirement for more
perceived solidity at the mouth end (perhaps b7 use of a baffle), stick
use/depletion indication, improved (preferrably single stick) inner wrap,
improved pack design (In terms'of function and appearance).
While ATP are Largely aware of these aspects, the use of a
panel of 'innovation sensitivet consumers, such as are available in the
UK for qualitative evaluation is strongly indicated.
Conclusion
Sensible support for ATr should be designed to run in step ~rlth
the current pragmatic empirical approach, avoiding the temptation to 'go
fundamental' and aiming to ~atch up FAVOR performance against what we
know of the 8eneory/behavioural performance of conventional cigarettes.
R.P. FERRIS
O
C7~
Cr~
ClibPDF - www.fastio.com

This to to confirm that my personalpar:tclpatlon in ~mrter
Research actl~rltles is on an entirely voluntary basis and of ~, ovn free
rill under the following terms:
le
6
~e
That my relatlonship to Charter Research representatives be governed
b7 ethical ~uldellnes currently isld down by the Rrltlsb Psychological
Soctet7 pertaining to the pro£esslo~al conduct of PsTchologlsts-
That m7 relatlonshlp to Charter Research representatives be governed
by the Xarket Research SocletT code of conduct.
That, in the case of any exerclsee l=lvin~ produce evaluation,
products e~sloated should be of marketable standard.
I have read, understand and accept the above conditions regarding
"wy voluntary relationship to Charter Research Associates.
Signed • • • ....... •
Dated . • • • • ... • • • •
.....=b
C~
ClibPDF - www.fastio.com

---
